Augtyro (repotrectinib)

AUGTYRO is a medicine for grown-ups with a specific type of lung cancer called ROS1-positive non-small cell lung cancer (NSCLC) that has spread within the lungs or to other parts.

Dosage and Administration: Doctors check for ROS1 changes in the tumor before giving AUGTYRO to patients with advanced or spread-out lung cancer. The usual dose is 160 mg as capsules once a day for two weeks, then it’s increased to 160 mg twice a day. It can be taken with or without food.

• Central Nervous System (CNS) Effects: It might cause problems like dizziness or trouble thinking. If it happens, the doctor might pause the medicine and start again at the same or lower dose or stop it.
  
• Lung Problems: Patients need to watch out for new or worse breathing problems. If there’s suspicion of lung issues, the doctor might pause the medicine, and if confirmed, stop it.
  
• Liver Issues: Regular liver tests are needed during the first month of treatment. Depending on the results, the doctor might stop or lower the dose.
  
• Muscle Problems: Patients need to report any unexplained muscle pain or weakness. Depending on how bad it is, the doctor might pause or lower the dose.
  
• High Uric Acid Levels: Doctors need to keep an eye on uric acid levels in the blood. Medicine might be needed to lower it. The doctor might pause, lower the dose, or stop the medicine based on how severe it is.
  
• Bone Fractures: If patients feel pain or notice changes in how they move, they should see the doctor quickly.
  
• Pregnancy Risks: Women who might have a baby should use effective birth control as this medicine might harm an unborn baby.

If you’re considering importing Augtyro™ (repotrectinib) to India, note that the import process requires specific documentation and follows stringent regulations:

Required Documentation for Import:

• A valid prescription from a certified medical professional.
  
• Patient’s diagnostic reports.
  
• Government-issued identification recognized by the Government of India.

Order Confirmation Process:

To confirm an order for Augtyro™, you’ll need:

• A valid prescription from a certified doctor.
  
• Any necessary import permits.

Augtyro™ (repotrectinib) is a prescription drug and necessitates a doctor’s prescription for dispensation. Indian Pharma Network (IPN) specializes in sourcing cancer medicines through named patient supply (NPS) from reputable suppliers globally.

Augtyro™ can be accessed across various Indian cities like Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, and more. To place an order, a doctor’s prescription and import permit are mandatory.

IPN is committed to supplying Augtyro™ (prescription medicines) in compliance with legal requirements, both domestically and internationally. For price inquiries and initiating the ordering process.

What is Repotrectinib?

Repotrectinib is a medication categorized as a tyrosine kinase inhibitor. It’s being studied for its potential in treating certain types of cancers, particularly those carrying specific genetic mutations.

What types of cancer is Repotrectinib used for?

Repotrectinib is being researched for its effectiveness against cancers like non-small cell lung cancer (NSCLC), gastrointestinal stromal tumors (GIST), and other solid tumors with specific genetic alterations.

How does Repotrectinib work?

As a tyrosine kinase inhibitor, Repotrectinib targets specific proteins in cancer cells, hindering their growth and ability to spread. By blocking these proteins, it aims to stop or slow down the progression of cancer.

Is Repotrectinib available for regular use?

Currently, Repotrectinib is in clinical trials, undergoing testing to determine its safety and efficacy. It’s not yet approved as a standard treatment and is typically accessed through clinical trial participation.

What’s the significance of Repotrectinib in cancer treatment?

Repotrectinib offers hope as a potential treatment option for cancers with specific genetic mutations. It’s being investigated for its ability to target these mutations, potentially providing a more tailored and effective therapy.